A fast-acting nasal spray was safe and effective for patients self-treating for repeated episodes of paroxysmal supraventricular tachycardia during long-term follow-up, according to findings from the open-label NODE-302 study.
There is an unmet need for a safe, rapid, self-treatment of paroxysmal supraventricular tachycardia (PSVT) in a medically unsupervised setting, James E. Ip, MD, FHRS, associate professor of clinical medicine and clinical cardiac electrophysiologist at Weill Cornell Medicine and New York-Presbyterian Hospital, said during a presentation at Heart Rhythm 2022.
“There